First description of atrial fibrillation and congenital thrombotic thrombocytopenic purpura treated by left atrial appendage occlusion.

Hussain Basrawala, Katherine Finley, Michael Jaglal, Bibhu D Mohanty

Open access · diamondAbstract read

In one paragraph

Article in EJHaem, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.2field-weighted citation impact, top 47% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

First description of atrial fibrillation and congenital thrombotic thrombocytopenic purpura treated by left atrial appendage occlusion.EJHaem · 2023
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hussain BasrawalaDepartment of Cardiovascular Sciences, University of South Florida Morsani College of Medicine Tampa Florida USA.

Katherine FinleyDepartment of Internal Medicine, University of South Florida Morsani College of Medicine Tampa Florida USA.ORCID https://orcid.org/0000-0001-9190-9639

Michael JaglalDepartment of Hematology and Oncology, University of South Florida Morsani College of Medicine Tampa Florida USA.ORCID https://orcid.org/0000-0002-4305-2535

Bibhu D MohantyDepartment of Cardiovascular Sciences, University of South Florida Morsani College of Medicine Tampa Florida USA.

University of South Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Given an increased risk of both thrombosis and bleeding, thrombotic thrombocytopenic purpura (TTP) presents a unique challenge when anticoagulation is required for comorbid disease, particularly in the setting of major bleeding events. We present for the first time a patient with TTP and atrial fibrillation, presenting with recurrent stroke, but unable to tolerate anticoagulation due to prior intra-cerebral hemorrhage. To address both issues concomitantly, we describe the successful application of a novel management approach to facilitate left atrial appendage occlusion, there by offering a non-pharmacologic means of stroke prevention without added bleeding risk.

Indexed as

Anticoagulationatrial fibrillationLAAOleft atrial appendageocclusionpurpurastrokethrombocytopeniathrombocytopenicthromboembolicthrombosisthromboticTTPWatchman

Identifiers

PMID37206280

DOI10.1002/jha2.659

PMCPMC10188452

OpenAlexW4323075218

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.